InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 23.98 CNY -2.24%
Market Cap: 20.2B CNY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 24.91 CNY with a low forecast of 23.33 CNY and a high forecast of 27.03 CNY.

Lowest Forecast
Wall Street Target
23.33 CNY
3% Downside
Average Forecast
Wall Street Target
24.91 CNY
4% Upside
Highest Forecast
Wall Street Target
27.03 CNY
13% Upside
Lowest
Price Target
23.33 CNY
3% Downside
Average
Price Target
24.91 CNY
4% Upside
Highest
Price Target
27.03 CNY
13% Upside
InnoCare Pharma Ltd Competitors:
Price Targets
600161
Beijing Tiantan Biological Products Corp Ltd
56% Upside
RCUS
Arcus Biosciences Inc
198% Upside
S
096530
Seegene Inc
29% Upside
LTRN
Lantern Pharma Inc.
554% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
56% Upside
RCUS
Arcus Biosciences Inc
198% Upside
S
096530
Seegene Inc
29% Upside
LTRN
Lantern Pharma Inc.
554% Upside
ALDX
Aldeyra Therapeutics Inc
245% Upside
IGMS
IGM Biosciences Inc
59% Upside
CSL
CSL Ltd
32% Upside
9926
Akeso Inc
32% Upside

Revenue
Forecast

Revenue Estimate
InnoCare Pharma Ltd

For the last 3 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

-1%
Past Growth
33%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InnoCare Pharma Ltd's stock price target?
Price Target
24.91 CNY

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 24.91 CNY with a low forecast of 23.33 CNY and a high forecast of 27.03 CNY.

What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for InnoCare Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.